<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:06:38Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10685946" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10685946</identifier>
        <datestamp>2023-11-30</datestamp>
        <setSpec>bmjo</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">BMJ Open</journal-id>
              <journal-id journal-id-type="iso-abbrev">BMJ Open</journal-id>
              <journal-id journal-id-type="hwp">bmjopen</journal-id>
              <journal-id journal-id-type="publisher-id">bmjopen</journal-id>
              <journal-title-group>
                <journal-title>BMJ Open</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2044-6055</issn>
              <publisher>
                <publisher-name>BMJ Publishing Group</publisher-name>
                <publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10685946</article-id>
              <article-id pub-id-type="pmcid">PMC10685946</article-id>
              <article-id pub-id-type="pmc-uid">10685946</article-id>
              <article-id pub-id-type="pmid">38011967</article-id>
              <article-id pub-id-type="pmid">38011967</article-id>
              <article-id pub-id-type="publisher-id">bmjopen-2023-075157</article-id>
              <article-id pub-id-type="doi">10.1136/bmjopen-2023-075157</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Public Health</subject>
                </subj-group>
                <subj-group subj-group-type="hwp-journal-coll">
                  <subject>1506</subject>
                  <subject>1724</subject>
                </subj-group>
                <series-title>Protocol</series-title>
              </article-categories>
              <title-group>
                <article-title>Increasing the reach of evidence-based interventions for weight management and diabetes prevention among Medicaid patients: study protocol for a pilot Sequential Multiple Assignment Randomised Trial</article-title>
              </title-group>
              <contrib-group>
                <contrib id="author-97544250" contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8355-6316</contrib-id>
                  <name>
                    <surname>Schlechter</surname>
                    <given-names>Chelsey R</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">1</xref>
                  <xref rid="aff2" ref-type="aff">2</xref>
                </contrib>
                <contrib id="author-28659890" contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9954-6799</contrib-id>
                  <name>
                    <surname>Del Fiol</surname>
                    <given-names>Guilherme</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">3</xref>
                </contrib>
                <contrib id="author-107572301" contrib-type="author">
                  <name>
                    <surname>Jones</surname>
                    <given-names>Dusti R</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">1</xref>
                  <xref rid="aff2" ref-type="aff">2</xref>
                </contrib>
                <contrib id="author-107572302" contrib-type="author">
                  <name>
                    <surname>Orleans</surname>
                    <given-names>Brian</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">2</xref>
                </contrib>
                <contrib id="author-100922250" contrib-type="author">
                  <name>
                    <surname>Gibson</surname>
                    <given-names>Bryan</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">3</xref>
                </contrib>
                <contrib id="author-107572304" contrib-type="author">
                  <name>
                    <surname>Nahum-Shani</surname>
                    <given-names>Inbal</given-names>
                  </name>
                  <xref rid="aff4" ref-type="aff">4</xref>
                </contrib>
                <contrib id="author-101670604" contrib-type="author">
                  <name>
                    <surname>Maxfield</surname>
                    <given-names>Ellen</given-names>
                  </name>
                  <xref rid="aff5" ref-type="aff">5</xref>
                  <xref rid="aff6" ref-type="aff">6</xref>
                </contrib>
                <contrib id="author-103077848" contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-6127-5361</contrib-id>
                  <name>
                    <surname>Locke</surname>
                    <given-names>Amy</given-names>
                  </name>
                  <xref rid="aff5" ref-type="aff">5</xref>
                  <xref rid="aff6" ref-type="aff">6</xref>
                </contrib>
                <contrib id="author-107572307" contrib-type="author">
                  <name>
                    <surname>Cornia</surname>
                    <given-names>Ryan</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">3</xref>
                </contrib>
                <contrib id="author-107572308" contrib-type="author">
                  <name>
                    <surname>Bradshaw</surname>
                    <given-names>Richard</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">3</xref>
                </contrib>
                <contrib id="author-107572309" contrib-type="author">
                  <name>
                    <surname>Wirth</surname>
                    <given-names>Jennifer</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">2</xref>
                </contrib>
                <contrib id="author-107572310" contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0006-7191-9489</contrib-id>
                  <name>
                    <surname>Jaggers</surname>
                    <given-names>Shanna J</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">2</xref>
                </contrib>
                <contrib id="author-107572311" contrib-type="author">
                  <name>
                    <surname>Lam</surname>
                    <given-names>Cho Y</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">1</xref>
                  <xref rid="aff2" ref-type="aff">2</xref>
                </contrib>
                <contrib id="author-63092397" contrib-type="author">
                  <name>
                    <surname>Wetter</surname>
                    <given-names>David W</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">1</xref>
                  <xref rid="aff2" ref-type="aff">2</xref>
                </contrib>
              </contrib-group>
              <aff id="aff1"><label>1</label><institution content-type="department">Department of Population Health Sciences</institution>, <institution specific-use="Ringgold_14434">University of Utah</institution>, <addr-line content-type="city">Salt Lake City</addr-line>, <addr-line content-type="state">Utah</addr-line>, <country>USA</country></aff>
              <aff id="aff2"><label>2</label><institution content-type="department">Huntsman Cancer Institute</institution>, <institution specific-use="Ringgold_20270">University of Utah</institution>, <addr-line content-type="city">Salt Lake City</addr-line>, <addr-line content-type="state">Utah</addr-line>, <country>USA</country></aff>
              <aff id="aff3"><label>3</label><institution content-type="department">Department of Biomedical Informatics</institution>, <institution>University of Utah</institution>, <addr-line content-type="city">Salt Lake City</addr-line>, <addr-line content-type="state">Utah</addr-line>, <country>USA</country></aff>
              <aff id="aff4"><label>4</label><institution content-type="department">Institute for Social Research</institution>, <institution specific-use="Ringgold_1259">University of Michigan</institution>, <addr-line content-type="city">Ann Arbor</addr-line>, <addr-line content-type="state">Michigan</addr-line>, <country>USA</country></aff>
              <aff id="aff5"><label>5</label><institution content-type="department">Osher Center for Integrative Health</institution>, <institution specific-use="Ringgold_266111">University of Utah</institution>, <addr-line content-type="city">Salt Lake City</addr-line>, <addr-line content-type="state">Utah</addr-line>, <country>USA</country></aff>
              <aff id="aff6"><label>6</label><institution content-type="department">Department of Family &amp; Preventive Medicine</institution>, <institution specific-use="Ringgold_14434">University of Utah</institution>, <addr-line content-type="city">Salt Lake City</addr-line>, <addr-line content-type="state">Utah</addr-line>, <country>USA</country></aff>
              <author-notes>
                <corresp><label>Correspondence to</label> Dr Chelsey R Schlechter; <email>Chelsey.schlechter@hci.utah.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="collection">
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>27</day>
                <month>11</month>
                <year>2023</year>
              </pub-date>
              <volume>13</volume>
              <issue>11</issue>
              <elocation-id>e075157</elocation-id>
              <history>
                <date date-type="received">
                  <day>28</day>
                  <month>4</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>16</day>
                  <month>10</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.</copyright-statement>
                <copyright-year>2023</copyright-year>
                <ali:free_to_read/>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense" start_date="2023-11-27">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
                </license>
              </permissions>
              <self-uri xlink:title="pdf" xlink:href="bmjopen-2023-075157.pdf"/>
              <self-uri content-type="reviewers-comments-pdf" xlink:href="bmjopen-2023-075157.reviewer_comments.pdf"/>
              <self-uri content-type="draft-revisions-pdf" xlink:href="bmjopen-2023-075157.draft_revisions.pdf"/>
              <abstract>
                <sec>
                  <title>Introduction</title>
                  <p>Over 40% of US adults meet criteria for obesity, a major risk factor for chronic disease. Obesity disproportionately impacts populations that have been historically marginalised (eg, low socioeconomic status, rural, some racial/ethnic minority groups). Evidence-based interventions (EBIs) for weight management exist but reach less than 3% of eligible individuals. The aims of this pilot randomised controlled trial are to evaluate feasibility and acceptability of dissemination strategies designed to increase reach of EBIs for weight management.</p>
                </sec>
                <sec>
                  <title>Methods and analysis</title>
                  <p>This study is a two-phase, Sequential Multiple Assignment Randomized Trial, conducted with 200 Medicaid patients. In phase 1, patients will be individually randomised to single text message (TM1) or multiple text messages (TM+). Phase 2 is based on treatment response. Patients who enrol in the EBI within 12 weeks of exposure to phase 1 (ie, responders) receive no further interventions. Patients in TM1 who do not enrol in the EBI within 12 weeks of exposure (ie, TM1 non-responders) will be randomised to either TM1-Continued (ie, no further TM) or TM1 &amp; MAPS (ie, no further TM, up to 2 Motivation And Problem Solving (MAPS) navigation calls) over the next 12 weeks. Patients in TM+ who do not enrol in the EBI (ie, TM+ non-responders) will be randomised to either TM+Continued (ie, monthly text messages) or TM+ &amp; MAPS (ie, monthly text messages, plus up to 2 MAPS calls) over the next 12 weeks. Descriptive statistics will be used to characterise feasibility (eg, proportion of patients eligible, contacted and enrolled in the trial) and acceptability (eg, participant opt-out, participant engagement with dissemination strategies, EBI reach (ie, the proportion of participants who enrol in EBI), adherence, effectiveness).</p>
                </sec>
                <sec>
                  <title>Ethics and dissemination</title>
                  <p>Study protocol was approved by the University of Utah Institutional Review Board (#00139694). Results will be disseminated through study partners and peer-reviewed publications.</p>
                </sec>
                <sec>
                  <title>Trial registration number</title>
                  <p>clinicaltrials.gov; <ext-link xlink:href="NCT05666323" ext-link-type="ClinicalTrials.gov">NCT05666323</ext-link>.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>public health</kwd>
                <kwd>obesity</kwd>
                <kwd>health equity</kwd>
                <kwd>health informatics</kwd>
                <kwd>telemedicine</kwd>
              </kwd-group>
              <funding-group specific-use="FundRef">
                <award-group id="funding-1">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010637</institution-id>
                      <institution>Huntsman Cancer Foundation</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-2">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006108</institution-id>
                      <institution>National Center for Advancing Translational Sciences</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>UL1TR002538</award-id>
                </award-group>
                <award-group id="funding-3">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id>
                      <institution>National Cancer Institute</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>P30CA042014</award-id>
                </award-group>
                <award-group id="funding-4">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006415</institution-id>
                      <institution>Ben B. and Iris M. Margolis Foundation</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>special-feature</meta-name>
                  <meta-value>unlocked</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <boxed-text id="BX1" position="float">
              <caption>
                <title>STRENGTHS AND LIMITATIONS OF THIS STUDY</title>
              </caption>
              <list list-type="bullet">
                <list-item>
                  <p>Uses an innovative Sequential Multiple Assignment Randomized Trial design to optimise adaptive interventions.</p>
                </list-item>
                <list-item>
                  <p>Potential reach and sustainability are enhanced by using dissemination strategy modalities (ie, cellphone-based voice and text) that are ubiquitous among adults in the USA, including among historically marginalised populations, and are already utilised by payers and healthcare systems.</p>
                </list-item>
                <list-item>
                  <p>Participant population was drawn from a single healthcare system in a single state.</p>
                </list-item>
              </list>
            </boxed-text>
            <sec sec-type="intro" id="s1">
              <title>Introduction</title>
              <p>Approximately 40% of US adults meet criteria for obesity (BMI ≥30),<xref rid="R1" ref-type="bibr">1</xref> and this proportion is expected to rise to nearly 50% in the next decade.<xref rid="R2" ref-type="bibr">2</xref> Obesity is a leading risk factor for multiple chronic diseases, including at least 13 different cancers,<xref rid="R3" ref-type="bibr">3–5</xref> type 2 diabetes,<xref rid="R6" ref-type="bibr">6 7</xref> cardiovascular disease<xref rid="R8" ref-type="bibr">8 9</xref> and premature death.<xref rid="R10" ref-type="bibr">10</xref> Additionally, obesity plays a critical role in health inequities, disproportionately impacting low socioeconomic status (SES), rural and many racial/ethnic minority populations.<xref rid="R11" ref-type="bibr">11–15</xref> For example, individuals with lower levels of education have higher obesity rates compared with those with higher levels of education.<xref rid="R16" ref-type="bibr">16</xref> Recent studies have found obesity rates of 41% among rural US adults versus 32% among urban residents, and rising BMI among rural populations has been a principal contributor to the obesity epidemic<xref rid="R17" ref-type="bibr">17 18</xref> over the last 30 years. Finally, obesity is more prevalent among Latino adults compared with non-Latino white adults (45.6% and 41.4%, respectively).<xref rid="R15" ref-type="bibr">15</xref></p>
              <sec id="s1-1">
                <title>Evidence-based weight management and diabetes prevention programmes</title>
                <p>Recommendations from the US Preventive Services Task Force and others highlight that adults with obesity should engage in comprehensive, multicomponent behavioural interventions addressing weight, diet and physical activity.<xref rid="R19" ref-type="bibr">19–22</xref> Components of these behavioural evidence-based interventions (EBIs) include improving diet and nutrition, increasing physical activity and behavioural strategies such as goal setting and self-monitoring.<xref rid="R23" ref-type="bibr">23</xref> The Diabetes Prevention Program (DPP) is among the most well-known EBIs for weight management, with substantial evidence for weight loss, increased physical activity, decreased daily energy intake and decreased incidence of type 2 diabetes.<xref rid="R24" ref-type="bibr">24</xref> The DPP can be delivered via in-person or digital modalities, and there are currently over 1800 Centers for Disease Control and Prevention (CDC) recognised DPP programmes across the USA.<xref rid="R25" ref-type="bibr">25</xref> Despite their effectiveness, DPPs are grossly underutilised,<xref rid="R26" ref-type="bibr">26</xref> reaching only 3% of eligible individuals.<xref rid="R27" ref-type="bibr">27</xref> Furthermore, there are substantial disparities in DPP access (14.6% of rural counties contain a DPP site vs 48.4% for urban counties)<xref rid="R28" ref-type="bibr">28</xref> and engagement among historically marginalised populations (eg, low SES, Latino).<xref rid="R26" ref-type="bibr">26 29</xref> Barriers to participation for in-person delivered DPPs among historically marginalised populations include the need to travel long distances, and the lack of transportation, financial resources, childcare and time. Fortunately, digital DPP delivery modalities such as the telephone, web-based and smartphones have yielded weight loss and other outcomes comparable to in-person DPPs, with greater engagement and lower attrition in digital programmes.<xref rid="R24" ref-type="bibr">24 26 30–34</xref> Consistent with those findings, the Community Preventive Services Task Force concluded that ‘Technology-Supported Multicomponent Coaching or Counseling Interventions’ are recommended for both weight loss and weight loss maintenance<xref rid="R20" ref-type="bibr">20</xref> and that technology-supported programmes may increase access among populations that have transportation issues, have unusual work schedules or are rural. Similarly, the National Academy of Medicine report on obesity treatment identified key research recommendations that included improving access, employing technology to increase reach and reducing health disparities.<xref rid="R21" ref-type="bibr">21</xref></p>
              </sec>
              <sec id="s1-2">
                <title>Dissemination strategies to increase EBI reach</title>
                <p>Dissemination strategies are designed to increase the reach of EBIs by increasing individual motivation and capability to access and engage with the interventions.<xref rid="R35" ref-type="bibr">35 36</xref> Many strategies to increase the reach of weight management EBIs rely on dissemination strategies at the point of care (eg, provider referral to EBI).<xref rid="R37" ref-type="bibr">37–39</xref> However, other potent strategies for increasing reach include proactive, population health management approaches that can remove the burden from clinical staff to offer the referral and can also reach out to all appropriate patients without the need for a clinical visit to trigger the referral offer. Population health management approaches have increased referrals to EBIs for weight management<xref rid="R27" ref-type="bibr">27 37</xref> and enrolment in EBIs among eligible participants.<xref rid="R40" ref-type="bibr">40 41</xref></p>
                <p>Digital and telehealth dissemination strategies such as text messaging and phone-based health coaching are promising approaches to improve dissemination of EBIs for weight management and have near ubiquitous reach given 97% of Americans own a cellphone, including 97% of individuals with income less than $30 000 per year, 94% of rural individuals and nearly 100% of Hispanic individuals.<xref rid="R42" ref-type="bibr">42</xref> Text messaging has been effective for improving numerous health behaviours (eg, physical activity, nutrition and tobacco cessation) and for improving attendance and compliance with behavioural interventions.<xref rid="R43" ref-type="bibr">43–48</xref> Similarly, personalised support to address barriers to care via patient navigation has been shown to improve completion rates for cancer screening, increase adherence to medication, improve compliance to treatment and follow-up visits, improve biomarkers for diabetes and increase enrolment in EBIs.<xref rid="R49" ref-type="bibr">49–52</xref> However, there is limited research on the effectiveness of these approaches for increasing reach of EBIs for weight management among historically marginalised populations.</p>
              </sec>
              <sec id="s1-3">
                <title>Adaptive interventions</title>
                <p>Adaptive interventions contain a sequence of individually tailored decision rules that specify the intensity or type of intervention at critical points in the delivery of care.<xref rid="R53" ref-type="bibr">53–55</xref> Modifying intensity or type of intervention over time can improve outcomes if an individual is not responding or may reduce costs and burden if intensive treatment is not necessary.<xref rid="R56" ref-type="bibr">56</xref> For example, a stepped care model (a type of adaptive intervention) can conserve scarce resources and reduce burden on patients. Sequential Multiple Assignment Randomized Trials (SMART<xref rid="R57" ref-type="bibr">57 58</xref>) are a type of experimental design used to inform the dosage, type, delivery and timing of adaptive interventions.</p>
              </sec>
              <sec id="s1-4">
                <title>Aims and objectives</title>
                <p>The overall aims of this pilot study are to evaluate the feasibility and acceptability of the dissemination strategies and study procedures. Feasibility will be measured by the proportion of people who were eligible, contacted and randomised in the trial. Acceptability will be assessed by rate of participant opt-out, participant engagement with dissemination strategies, EBI reach by randomisation condition, and EBI adherence and effectiveness among participants who enrol in the EBI.</p>
              </sec>
            </sec>
            <sec sec-type="methods" id="s2">
              <title>Methods and analysis</title>
              <p>The protocol for this pilot study has been reviewed and approved by the University of Utah Institutional Review Board. As study interventions were deemed no more than minimal risk, documentation of informed consent was waived for the project. All participants will be notified of the study and given the opportunity to opt-out of the project using a cover letter.</p>
              <p>Data collection was planned to begin in March 2022 and end in May 2023. The trial is registered at clinicaltrials.gov (NCT05666323). This manuscript adheres to the Standard Protocol Items: Recommendations for Interventional Trials.</p>
              <sec id="s2-1">
                <title>Settings and participants</title>
                <p>Participants will be 200 adults (1) age ≥18; (2) BMI ≥30; (3) have had a primary care appointment within University of Utah Health (UHealth) within the past 12 months; (4) speak English or Spanish as their primary language; (5) have a current Utah address and (6) are insured through Medicaid by the University of Utah Health Plans. Exclusion criteria include (1) a diagnosis of type 1 or type 2 diabetes, (2) documented current pregnancy and (3) no phone number listed in the electronic health record (EHR).</p>
              </sec>
              <sec id="s2-2">
                <title>Study design</title>
                <p>This trial is a two-phase SMART with 200 Medicaid patients from a single academic medical system (<xref rid="F1" ref-type="fig">figure 1</xref>). In the first phase, participants will be individually randomised to receive a single text message (TM1) or multiple text messages (TM+) offering free enrolment in a digital EBI for weight management.</p>
                <fig position="float" id="F1">
                  <label>Figure 1</label>
                  <caption>
                    <p>Sequential Multiple Assignment Randomised Trial study design.</p>
                  </caption>
                  <graphic xlink:href="bmjopen-2023-075157f01" position="float"/>
                </fig>
                <p>Phase 2 dissemination strategies are randomised based on prior dissemination strategy response. Participants in TM1 who do not opt out or enrol in the EBI by 12 weeks will be randomised to either TM1-Continued (no further TM) or TM1 &amp; MAPS (no further TM and up to 2 Motivation And Problem Solving (MAPS) calls from a patient navigator). Participants in TM+ who do not opt out or enrol in the EBI by 12 weeks will be randomised to either TM+Continued (monthly text messages for the next 12 weeks) or TM+ &amp; MAPS (monthly text messages for the next 12 weeks, plus up to 2 MAPS calls from a patient navigator). Descriptions of participant randomisation conditions are listed in <xref rid="T1" ref-type="table">table 1</xref>.</p>
                <table-wrap position="float" id="T1">
                  <label>Table 1</label>
                  <caption>
                    <p>Randomisation condition description</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <thead>
                      <tr>
                        <td align="left" valign="bottom" rowspan="1" colspan="1"/>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Randomisation condition</td>
                        <td align="left" valign="bottom" rowspan="1" colspan="1">Description</td>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" valign="top" colspan="3" rowspan="1">Phase 1</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1">Single text message (TM1)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Participants receive a single text message that includes a motivational message, the EBI phone number, and a two-touch response that directly connects interested participants to EBI enrolment</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1">Multiple text message (TM+)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Participants receive messages once per week for the first 2 weeks, then 1 message every 3 weeks for the remaining 10 weeks (up to five texts total). The text messages include a motivational message, the EBI phone number and a simple two-touch response that directly connects interested participants to EBI enrolment</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" colspan="3" rowspan="1">Phase 2</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="2" colspan="1">For TM1 non-responding participants only</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Single text message continued (TM1-Cont)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Participants receive no additional text messages</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Single text message &amp; Motivation And Problem Solving (MAPS) (TM1 &amp; MAPS)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Participants receive no additional text messages and receive up to 2 MAPS counselling calls from a health coach</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="2" colspan="1">For TM+ non-responding participants only</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Multiple text message continued (TM+-Cont)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Participants receive text messages every 4 weeks for the next 12 weeks (up to three text messages total)</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Multiple text message &amp; MAPS (TM+ &amp; MAPS)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Participants receive text messages every 4 weeks for the next 12 weeks (up to three text messages total) plus up to 2 MAPS counselling calls from a health coach</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="T1_FN1">
                      <p>EBI, evidence-based intervention.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="s2-3">
                <title>Dissemination strategies</title>
                <sec id="s2-3-1">
                  <title>Text messaging</title>
                  <p>Participants will receive bidirectional Health Insurance Portability and Accountability Act compliant text messages that include a brief motivational message, the opportunity to enrol in the EBI, and the opportunity to opt out of receiving further dissemination strategies.</p>
                </sec>
                <sec id="s2-3-2">
                  <title>MAPS health coaching</title>
                  <p>Participants will receive up to two brief calls from health coaches trained in using MAPS, a coaching/counselling approach designed to help participants address the larger context in which behaviour change occurs, identify and address barriers to change, and motivate participants towards a long-term goal of change. MAPS is a holistic, dynamic behavioural approach that integrates two empirically validated approaches (motivational interviewing<xref rid="R59" ref-type="bibr">59 60</xref> and problem-solving/social cognitive strategies<xref rid="R61" ref-type="bibr">61–63</xref>) into a coordinated intervention with demonstrated efficacy for addressing the entire process of considering behaviour change, attempting to change and maintaining change.<xref rid="R50" ref-type="bibr">50 63–66</xref> MAPS employs a ‘wellness’ approach that in addition to focusing on the target behaviour, provides practical advice and connections to additional services whenever possible for life events, stressors and concerns that impact the lives of rural and other historically marginalised individuals (eg, isolation, stress, depression, financial barriers, etc). MAPS is based on substantial evidence that motivation fluctuates frequently and rapidly and as such, is designed to fluidly respond to those changes.<xref rid="R67" ref-type="bibr">67–70</xref> MAPS health coaching calls will be delivered by two bilingual health coaches on the research team with at least 20 hours of training in MAPS delivery.</p>
                </sec>
              </sec>
              <sec id="s2-4">
                <title>Digital EBI for diabetes prevention and weight management</title>
                <p>Participants who enrol in the EBI will receive either a digital DPP or digital weight management programme based on criteria for meeting pre-diabetes. Participants will be evaluated for risk of pre-diabetes using the American Diabetes Association (ADA) and CDC Prediabetes Risk Test<xref rid="R71" ref-type="bibr">71</xref> at the time of enrolling in the EBI. The test uses only self-report health trait data (eg, family history, height, weight, physical activity level, health history of hypertension and gestational diabetes) and does not require testing data (ie, haemoglobin A1C or cholesterol levels). Participants who meet criteria for pre-diabetes based on the risk test will be triaged into a digital DPP; participants who do not meet criteria will be triaged to a digital weight management programme. Both programmes will be delivered by EBI vendor, IncentaHEALTH. Based on national data on eligibility for the DPP among individuals with obesity and data from the EBI provider, we estimate that ~50% of participants will be triaged to DPP and ~50% to weight management.<xref rid="R72" ref-type="bibr">72</xref></p>
                <p>The digital DPP offered to study participants is a CDC fully recognised programme. The digital weight management programme, for all participants who do not meet criteria for the DPP, uses the same general components as the DPP. Both programmes are designed to increase intake of fruits, vegetables, lean protein and complex carbohydrates while monitoring portion size. Physical activity recommendations include cardiovascular and strength training, with a goal of approximately 30 min 5–6 days/week. Both programmes are offered in English and Spanish, based on social cognitive theory, and provide personalised health coaching. Both include a website, a Bluetooth wireless scale for weight monitoring, daily email/text message support, easy to follow video exercise plans, customised meal plans, grocery lists, incorporate skill building and incorporate social accountability. Participants have unlimited access to health coaches, who have at least a Bachelor’s degree, along with certifications, in personal training, nutrition or wellness.</p>
              </sec>
              <sec id="s2-5">
                <title>Recruitment</title>
                <p>The flow of participants through the study is described in <xref rid="F2" ref-type="fig">figure 2</xref>. Participants who meet inclusion criteria will be identified from the UHealth Electronic Data Warehouse (EDW). Participant demographic, preferred language and relevant health data, as well as participant contact information (ie, phone number, address, email address), will be extracted from the EDW for all eligible participants. Participants who meet exclusionary criteria will be removed from the eligible population. We will use quota sampling from the eligible population to achieve a stratified random sample aimed to offer balance in the marginal distributions of key participant demographic characteristics. These margins include (1) male/female sex (1:1 ratio), (2) urban/rural according to participant zip code and the 2010 Rural Urban Commuting Area codes (≥4 defined as rural) (1:1 ratio) and (3) Latino with English as preferred language, Latino with Spanish as preferred language, and non-Latino with English as preferred language (1:1:3 ratio).</p>
                <fig position="float" id="F2">
                  <label>Figure 2</label>
                  <caption>
                    <p>Patient flow diagram.</p>
                  </caption>
                  <graphic xlink:href="bmjopen-2023-075157f02" position="float"/>
                </fig>
                <p>Sampled patients randomised to TM1 or TM+ will be sent an email informing them that they will be receiving communications from UHealth about the availability of a digital EBI for weight management. The email will provide patients with information about how they can opt out if they do not wish to receive these communications. Patients who do not have an email in the EHR will be sent the opt-out information via mail. Patients who opt out of the study receive no further interventions.</p>
              </sec>
              <sec id="s2-6">
                <title>Randomisation and blinding</title>
                <p>In phase 1 (<xref rid="F1" ref-type="fig">figure 1</xref>), participants will be randomly assigned to TM1 or TM+ in a 1:1 ratio. In phase 2 (<xref rid="F1" ref-type="fig">figure 1</xref>), participants who opt out or who enrol in the EBI will receive no further dissemination strategies and will not be rerandomised. Participants in TM1 did not opt out and who did not enrol in the EBI will be randomised to TM1-Cont or TM1 &amp; MAPS at a ratio of 1:1. Participants in TM+ who did not opt out and did not enrol in the EBI will be randomised to TM+-Cont or TM+ &amp; MAPS at a ratio of 1:1. All randomisation sequences will be generated via SAS 9.4 to consist of random permuted blocks with random block sizes, thus ensuring balance in the allocation over time.</p>
              </sec>
              <sec id="s2-7">
                <title>Data collection and outcomes</title>
                <p>Participant demographic and baseline health data (eg, age, gender, BMI, pregnancy status, medical codes for type 1 and type 2 diabetes, zip code, preferred language, race/ethnicity) will be obtained from the UHealth EDW.</p>
                <sec id="s2-7-1">
                  <title>Feasibility outcomes</title>
                  <p>Feasibility will be assessed using the proportion of participants who were eligible, contacted and enrolled in the trial.</p>
                </sec>
                <sec id="s2-7-2">
                  <title>Acceptability outcomes</title>
                  <p>Acceptability will be assessed using participant opt-out, participant engagement with dissemination strategies, EBI reach and EBI effectiveness. Participant opt-out is assessed by the absolute number and proportion of eligible participants who opt out during phases 1 and 2. Participant engagement will be assessed as (1) the number and proportion of participants who respond to text messages with a response other than opt-out, (2) the number and proportion of eligible participants who talk to a MAPS health coach, (3) the number and proportion of eligible participants accept connection to the EBI and (4) the number and proportion of participants who talk to the EBI personnel. EBI reach is assessed by the number and proportion of eligible participants who officially enrol in the EBI. Enrolment is defined in accordance with the CDC definition for recognised virtual programmes, which consists of the participant setting a password for the programme. Enrolment will be obtained from the EBI vendor (IncentaHEALTH). EBI adherence and effectiveness are measured by participant adherence to the EBI components, percentage of body weight lost and change in BMI and will be collected for 12 weeks following EBI enrolment. Adherence and effectiveness data will be obtained from the EBI vendor (IncentaHEALTH).</p>
                </sec>
              </sec>
              <sec id="s2-8">
                <title>Patient and public involvement</title>
                <p>This study was developed and implemented in collaboration with the University of Utah Wellness and Integrative Health Program, which supports population health initiatives through integration of wellness services into patient care and health plan offerings. The programme currently manages lifestyle behaviour change programmes (including the DPP) for UHealth patients and University of Utah faculty, staff and students. The dissemination strategies, the feasibility and acceptability outcomes, and study procedures were developed in collaboration with the University of Utah Wellness and Integrative Health Program and investigators at the University of Utah. Patients were not directly involved in the development of this pilot study.</p>
              </sec>
              <sec id="s2-9">
                <title>Ethics and dissemination</title>
                <p>All procedures performed in studies involving human participants will be conducted in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The protocol for this study was approved by the University of Utah Institutional Review Board (00139694). Materials used to conduct the study are not currently publicly available. Materials may be requested by emailing the corresponding author. Study results will be dissemination via peer-reviewed publications and manuscripts, as well as to the health system and community partners via lay reports and presentations.</p>
              </sec>
              <sec id="s2-10">
                <title>Data analysis plan</title>
                <p>Our primary study aim is to evaluate the acceptability and feasibility of dissemination strategies to increase of EBIs for weight management.</p>
                <sec id="s2-10-1">
                  <title>Primary analyses phase 1</title>
                  <p>The analysis of acceptability and feasibility at 12 weeks will include all participants enrolled in the study. We will use descriptive statistics (mean, SD, CI) to evaluate each indicator of feasibility and acceptability by dissemination strategies (ie, TM1, TM+).</p>
                </sec>
                <sec id="s2-10-2">
                  <title>Primary analyses phase 2</title>
                  <p>The analysis of feasibility and acceptability at 24 weeks will be conducted using only data from those participants who did not opt out or enrol in the EBIs by 12 weeks (ie, non-responders). We will use descriptive statistics to evaluate each indicator of feasibility and acceptability by dissemination strategies (ie, TM1-Cont, TM1 &amp; MAPS, TM+-Cont, TM+ &amp; MAPS).</p>
                </sec>
              </sec>
              <sec id="s2-11">
                <title>Power analysis</title>
                <p>The sample size (n=200) for the current project was determined based on feasibility of sample size recruitment from a single Medicaid provider and completing project procedures in the study timeframe. As such, power calculations were not conducted for this pilot trial.</p>
              </sec>
              <sec id="s2-12">
                <title>Strengths and limitations</title>
                <p>The proposed pilot study uses an innovative SMART design to optimise adaptive interventions to increase reach of already existing EBIs for weight management among historically marginalised populations. Potential reach and sustainability are enhanced by using dissemination strategy modalities (ie, cellphone-based voice and text) that are ubiquitous among adults in the USA, including among historically marginalised populations, and are already utilised by payers and healthcare systems. The participant population was drawn from a single healthcare system in a single state which may limit generalisability of results. However, the proposed study population will represent a diverse sample based on sex, ethnicity, primary language and rurality.</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="s3">
              <title>Conclusion</title>
              <p>The proposed pilot project is a two-phase SMART with the objective of evaluating acceptability and feasibility of dissemination strategies designed to increase the reach of digital EBIs for weight management among Medicaid patients. Accomplishing the aims of the proposed study will provide critical data regarding the feasibility and acceptability of pragmatic and scalable dissemination strategies designed to increase the uptake of digital EBIs for obesity among historically marginalised populations and inform the conduct of a future, fully powered randomised trial.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Material</title>
              <supplementary-material content-type="local-data" id="d64e265">
                <caption>
                  <title>Reviewer comments</title>
                </caption>
                <media xlink:href="bmjopen-2023-075157.reviewer_comments.pdf"/>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="d64e266">
                <caption>
                  <title>Author's
manuscript</title>
                </caption>
                <media xlink:href="bmjopen-2023-075157.draft_revisions.pdf"/>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn fn-type="other">
                <p><bold>Contributors:</bold> DWW acquired financial support for the project. CRS, GDF, BO, BG, EM, AL, JW, CYL, RB, RC, SJJ, INS and DWW contributed to study conceptualisation. All authors contributed to the development or design of the methodology, dissemination strategies, study procedures, study outcomes or analytic plan. CRS and DRJ drafted the original manuscript. All authors reviewed, edited and approved the final manuscript.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Funding:</bold> This work was supported through the Ben B and Iris M Margolis Foundation, the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1TR002538), the National Cancer Institute (P30CA042014) and the Huntsman Cancer Foundation.</p>
              </fn>
              <fn fn-type="COI-statement">
                <p><bold>Competing interests:</bold> None declared.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Patient and public involvement:</bold> Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p>
              </fn>
            </fn-group>
            <sec sec-type="ethics-statement">
              <title>Ethics statements</title>
              <sec>
                <title>Patient consent for publication</title>
                <p content-type="ethics-consent-to-publish">Not applicable.</p>
              </sec>
            </sec>
            <ref-list>
              <title>References</title>
              <ref id="R1">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hales</surname><given-names>CM</given-names></string-name>, <string-name><surname>Carroll</surname><given-names>MD</given-names></string-name>, <string-name><surname>Fryar</surname><given-names>CD</given-names></string-name></person-group>. <article-title>Prevalence of obesity and severe obesity among adults: United States, 2017–2018</article-title>. <source>NCHS Data Brief</source><year>2020</year>:<fpage>1</fpage>–<lpage>8</lpage>.</mixed-citation>
              </ref>
              <ref id="R2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ward</surname><given-names>ZJ</given-names></string-name>, <string-name><surname>Bleich</surname><given-names>SN</given-names></string-name>, <string-name><surname>Cradock</surname><given-names>AL</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Projected U.S. state-level prevalence of adult obesity and severe obesity</article-title>. <source>N Engl J Med</source><year>2019</year>;<volume>381</volume>:<fpage>2440</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMsa1909301</pub-id><pub-id pub-id-type="pmid">31851800</pub-id></mixed-citation>
              </ref>
              <ref id="R3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Islami</surname><given-names>F</given-names></string-name>, <string-name><surname>Goding Sauer</surname><given-names>A</given-names></string-name>, <string-name><surname>Miller</surname><given-names>KD</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Proportion and number of cancer cases and deaths attributable to potentially Modifiable risk factors in the United States</article-title>. <source>CA Cancer J Clin</source><year>2018</year>;<volume>68</volume>:<fpage>31</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.3322/caac.21440</pub-id><pub-id pub-id-type="pmid">29160902</pub-id></mixed-citation>
              </ref>
              <ref id="R4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Islami</surname><given-names>F</given-names></string-name>, <string-name><surname>Goding Sauer</surname><given-names>A</given-names></string-name>, <string-name><surname>Gapstur</surname><given-names>SM</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Proportion of cancer cases attributable to excess body weight by US state, 2011-2015</article-title>. <source>JAMA Oncol</source><year>2019</year>;<volume>5</volume>:<fpage>384</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1001/jamaoncol.2018.5639</pub-id><pub-id pub-id-type="pmid">30589925</pub-id></mixed-citation>
              </ref>
              <ref id="R5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McTiernan</surname><given-names>A</given-names></string-name>, <string-name><surname>Friedenreich</surname><given-names>CM</given-names></string-name>, <string-name><surname>Katzmarzyk</surname><given-names>PT</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Physical activity in cancer prevention and survival: A systematic review</article-title>. <source>Med Sci Sports Exerc</source><year>2019</year>;<volume>51</volume>:<fpage>1252</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1249/MSS.0000000000001937</pub-id><pub-id pub-id-type="pmid">31095082</pub-id></mixed-citation>
              </ref>
              <ref id="R6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Verma</surname><given-names>S</given-names></string-name>, <string-name><surname>Hussain</surname><given-names>ME</given-names></string-name></person-group>. <article-title>Obesity and diabetes: an update</article-title>. <source>Diabetes Metab Syndr</source><year>2017</year>;<volume>11</volume>:<fpage>73</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.dsx.2016.06.017</pub-id><pub-id pub-id-type="pmid">27353549</pub-id></mixed-citation>
              </ref>
              <ref id="R7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mokdad</surname><given-names>AH</given-names></string-name>, <string-name><surname>Ford</surname><given-names>ES</given-names></string-name>, <string-name><surname>Bowman</surname><given-names>BA</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001</article-title>. <source>JAMA</source><year>2003</year>;<volume>289</volume>:<fpage>76</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1001/jama.289.1.76</pub-id><pub-id pub-id-type="pmid">12503980</pub-id></mixed-citation>
              </ref>
              <ref id="R8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Powell-Wiley</surname><given-names>TM</given-names></string-name>, <string-name><surname>Poirier</surname><given-names>P</given-names></string-name>, <string-name><surname>Burke</surname><given-names>LE</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Obesity and cardiovascular disease: a scientific statement from the American heart Association</article-title>. <source>Circulation</source><year>2021</year>;<volume>143</volume>:<fpage>e984</fpage>–<lpage>1010</lpage>. <pub-id pub-id-type="doi">10.1161/CIR.0000000000000973</pub-id><pub-id pub-id-type="pmid">33882682</pub-id></mixed-citation>
              </ref>
              <ref id="R9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Khan</surname><given-names>SS</given-names></string-name>, <string-name><surname>Ning</surname><given-names>H</given-names></string-name>, <string-name><surname>Wilkins</surname><given-names>JT</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity</article-title>. <source>JAMA Cardiol</source><year>2018</year>;<volume>3</volume>:<fpage>280</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1001/jamacardio.2018.0022</pub-id><pub-id pub-id-type="pmid">29490333</pub-id></mixed-citation>
              </ref>
              <ref id="R10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hruby</surname><given-names>A</given-names></string-name>, <string-name><surname>Manson</surname><given-names>JE</given-names></string-name>, <string-name><surname>Qi</surname><given-names>L</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Determinants and consequences of obesity</article-title>. <source>Am J Public Health</source><year>2016</year>;<volume>106</volume>:<fpage>1656</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.2105/AJPH.2016.303326</pub-id><pub-id pub-id-type="pmid">27459460</pub-id></mixed-citation>
              </ref>
              <ref id="R11">
                <label>11</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><collab>AHRQ</collab></person-group>. <source>National Healthcare Quality and Disparities; Contract No.: AHRQ Publication no.19-0070-EF</source>. <publisher-loc>Rockville, MD</publisher-loc>: <publisher-name>Agency for Healthcare Research and Quality</publisher-name>, <year>2019</year>.</mixed-citation>
              </ref>
              <ref id="R12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Clarke</surname><given-names>AR</given-names></string-name>, <string-name><surname>Goddu</surname><given-names>AP</given-names></string-name>, <string-name><surname>Nocon</surname><given-names>RS</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Thirty years of disparities intervention research: what are we doing to close racial and ethnic gaps in health care</article-title><source>Med Care</source><year>2013</year>;<volume>51</volume>:<fpage>1020</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1097/MLR.0b013e3182a97ba3</pub-id><pub-id pub-id-type="pmid">24128746</pub-id></mixed-citation>
              </ref>
              <ref id="R13">
                <label>13</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Crosby</surname><given-names>RA</given-names></string-name>, <string-name><surname>Wendel</surname><given-names>ML</given-names></string-name>, <string-name><surname>Vanderpool</surname><given-names>RC</given-names></string-name></person-group>. <source>Rural populations and health: determinants, disparities, and solutions</source>. <publisher-loc>San Francisco, CA</publisher-loc>: <publisher-name>Jossey-Bass</publisher-name>, <year>2012</year>.</mixed-citation>
              </ref>
              <ref id="R14">
                <label>14</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><collab>National Center for Health Statistics</collab></person-group>. <source>Health, United States, 2011: With Special Feature on Socioeconomic Status and Health</source>. <publisher-loc>Hyattsville, MD</publisher-loc>: <publisher-name>National Center for Health Statistics (US)</publisher-name>, <year>2012</year>.</mixed-citation>
              </ref>
              <ref id="R15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Akinbami</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Chen</surname><given-names>T-C</given-names></string-name>, <string-name><surname>Davy</surname><given-names>O</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>National health and nutrition examination survey, 2017-March 2020 Prepandemic file: sample design, estimation, and analytic guidelines</article-title>. <source>Vital Health Stat 1</source><year>2022</year>:<fpage>1</fpage>–<lpage>36</lpage>.</mixed-citation>
              </ref>
              <ref id="R16">
                <label>16</label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Stierman</surname><given-names>B</given-names></string-name>, <string-name><surname>Afful</surname><given-names>J</given-names></string-name>, <string-name><surname>Carroll</surname><given-names>MD</given-names></string-name></person-group>. <article-title>National health and nutrition examination survey 2017–March 2020 Prepandemic data files development of files and prevalence estimates for selected health outcomes</article-title><year>2021</year>.</mixed-citation>
              </ref>
              <ref id="R17">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>NCD Risk Factor Collaboration (NCD-RisC)</collab></person-group>. <article-title>Rising rural body-mass index is the main driver of the global obesity epidemic in adults</article-title>. <source>Nature</source><year>2019</year>;<volume>569</volume>:<fpage>260</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-019-1171-x</pub-id><pub-id pub-id-type="pmid">31068725</pub-id></mixed-citation>
              </ref>
              <ref id="R18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wen</surname><given-names>M</given-names></string-name>, <string-name><surname>Fan</surname><given-names>JX</given-names></string-name>, <string-name><surname>Kowaleski-Jones</surname><given-names>L</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Rural–urban disparities in obesity prevalence among working age adults in the United States: exploring the mechanisms</article-title>. <source>Am J Health Promot</source><year>2018</year>;<volume>32</volume>:<fpage>400</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1177/0890117116689488</pub-id><pub-id pub-id-type="pmid">29214811</pub-id></mixed-citation>
              </ref>
              <ref id="R19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jensen</surname><given-names>MD</given-names></string-name>, <string-name><surname>Ryan</surname><given-names>DH</given-names></string-name>, <string-name><surname>Apovian</surname><given-names>CM</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American college of cardiology/American heart Association task force on practice guidelines and the obesity society</article-title>. <source>Circulation</source><year>2014</year>;<volume>129</volume>:<fpage>S102</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.0000437739.71477.ee</pub-id><pub-id pub-id-type="pmid">24222017</pub-id></mixed-citation>
              </ref>
              <ref id="R20">
                <label>20</label>
                <mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>Community Preventive Services Task Force</collab></person-group>. <source>Obesity: Technology-Supported multicomponent coaching or counseling interventions to maintain weight loss</source>. Available: <uri xlink:href="https://www.thecommunityguide.org/findings/obesity-technology-supported-multicomponent-coaching-or-counseling-interventions-maintain">https://www.thecommunityguide.org/findings/obesity-technology-supported-multicomponent-coaching-or-counseling-interventions-maintain</uri></mixed-citation>
              </ref>
              <ref id="R21">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Heymsfield</surname><given-names>S</given-names></string-name>, <string-name><surname>Aronne</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Eneli</surname><given-names>I</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Clinical perspectives on obesity treatment: challenges, gaps, and promising opportunities</article-title>. <source>NAM Perspectives</source><year>2018</year>;<volume>8</volume>. <comment>Available</comment><uri xlink:href="https://www.nam.edu/perspectives/">https://www.nam.edu/perspectives/</uri></mixed-citation>
              </ref>
              <ref id="R22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>LeBlanc</surname><given-names>ES</given-names></string-name>, <string-name><surname>Patnode</surname><given-names>CD</given-names></string-name>, <string-name><surname>Webber</surname><given-names>EM</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Behavioral and Pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults: updated evidence report and systematic review for the US preventive services task force</article-title>. <source>JAMA</source><year>2018</year>;<volume>320</volume>:<fpage>1172</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2018.7777</pub-id><pub-id pub-id-type="pmid">30326501</pub-id></mixed-citation>
              </ref>
              <ref id="R23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>US Preventive Services Task Force</collab>, <string-name><surname>Curry</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Krist</surname><given-names>AH</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US preventive services task force recommendation statement</article-title>. <source>JAMA</source><year>2018</year>;<volume>320</volume>:<fpage>1163</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2018.13022</pub-id><pub-id pub-id-type="pmid">30326502</pub-id></mixed-citation>
              </ref>
              <ref id="R24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dunkley</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Bodicoat</surname><given-names>DH</given-names></string-name>, <string-name><surname>Greaves</surname><given-names>CJ</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis</article-title>. <source>Diabetes Care</source><year>2014</year>;<volume>37</volume>:<fpage>922</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.2337/dc13-2195</pub-id><pub-id pub-id-type="pmid">24652723</pub-id></mixed-citation>
              </ref>
              <ref id="R25">
                <label>25</label>
                <mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>CDC</collab></person-group>. <source>Diabetes prevention recognition program – registry of recognized organizations</source>. Available: <uri xlink:href="https://nccd.cdc.gov/DDT_DPRP/Registry.aspx">https://nccd.cdc.gov/DDT_DPRP/Registry.aspx</uri></mixed-citation>
              </ref>
              <ref id="R26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ali</surname><given-names>MK</given-names></string-name>, <string-name><surname>McKeever Bullard</surname><given-names>K</given-names></string-name>, <string-name><surname>Imperatore</surname><given-names>G</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Reach and use of diabetes prevention services in the United States, 2016-2017</article-title>. <source>JAMA Netw Open</source><year>2019</year>;<volume>2</volume>:<elocation-id>e193160</elocation-id>.<pub-id pub-id-type="pmid">31074808</pub-id></mixed-citation>
              </ref>
              <ref id="R27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Alva</surname><given-names>ML</given-names></string-name>, <string-name><surname>Chakkalakal</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Moin</surname><given-names>T</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>The diabetes prevention gap and opportunities to increase participation in effective interventions</article-title>. <source>Health Aff (Millwood)</source><year>2022</year>;<volume>41</volume>:<fpage>971</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1377/hlthaff.2022.00259</pub-id><pub-id pub-id-type="pmid">35759735</pub-id></mixed-citation>
              </ref>
              <ref id="R28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ariel-Donges</surname><given-names>AH</given-names></string-name>, <string-name><surname>Gordon</surname><given-names>EL</given-names></string-name>, <string-name><surname>Dixon</surname><given-names>BN</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Rural/urban disparities in access to the National diabetes prevention program</article-title>. <source>Transl Behav Med</source><year>2020</year>;<volume>10</volume>:<fpage>1554</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/tbm/ibz098</pub-id><pub-id pub-id-type="pmid">31228199</pub-id></mixed-citation>
              </ref>
              <ref id="R29">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ritchie</surname><given-names>ND</given-names></string-name>, <string-name><surname>Christoe-Frazier</surname><given-names>L</given-names></string-name>, <string-name><surname>McFann</surname><given-names>KK</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Effect of the National diabetes prevention program on weight loss for English- and Spanish-speaking Latinos</article-title>. <source>Am J Health Promot</source><year>2018</year>;<volume>32</volume>:<fpage>812</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1177/0890117117698623</pub-id><pub-id pub-id-type="pmid">28320212</pub-id></mixed-citation>
              </ref>
              <ref id="R30">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Moin</surname><given-names>T</given-names></string-name>, <string-name><surname>Damschroder</surname><given-names>LJ</given-names></string-name>, <string-name><surname>AuYoung</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Results from a trial of an online diabetes prevention program intervention</article-title>. <source>Am J Prev Med</source><year>2018</year>;<volume>55</volume>:<fpage>583</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.amepre.2018.06.028</pub-id><pub-id pub-id-type="pmid">30262149</pub-id></mixed-citation>
              </ref>
              <ref id="R31">
                <label>31</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mudaliar</surname><given-names>U</given-names></string-name>, <string-name><surname>Zabetian</surname><given-names>A</given-names></string-name>, <string-name><surname>Goodman</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Cardiometabolic risk factor changes observed in diabetes prevention programs in US settings: a systematic review and meta-analysis</article-title>. <source>PLoS Med</source><year>2016</year>;<volume>13</volume>:<elocation-id>e1002095</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1002095</pub-id><pub-id pub-id-type="pmid">27459705</pub-id></mixed-citation>
              </ref>
              <ref id="R32">
                <label>32</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Taetzsch</surname><given-names>A</given-names></string-name>, <string-name><surname>Gilhooly</surname><given-names>CH</given-names></string-name>, <string-name><surname>Bukhari</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Development of a Videoconference-adapted version of the community diabetes prevention program, and comparison of weight loss with in-person program delivery</article-title>. <source>Mil Med</source><year>2019</year>;<volume>184</volume>:<fpage>647</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1093/milmed/usz069</pub-id><pub-id pub-id-type="pmid">31132088</pub-id></mixed-citation>
              </ref>
              <ref id="R33">
                <label>33</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tice</surname><given-names>J</given-names></string-name>, <string-name><surname>Chapman</surname><given-names>R</given-names></string-name>, <string-name><surname>Shore</surname><given-names>KK</given-names></string-name></person-group>. <article-title>Diabetes prevention programs: effectiveness and value: final evidence report and meeting summary</article-title>. <source>Institute for Clinical and Economic Review</source><year>2018</year>.</mixed-citation>
              </ref>
              <ref id="R34">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname><given-names>SE</given-names></string-name>, <string-name><surname>Castro Sweet</surname><given-names>CM</given-names></string-name>, <string-name><surname>Gibson</surname><given-names>E</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Evaluation of a Digital diabetes prevention program adapted for the Medicaid population: study design and methods for a non-randomized, controlled trial</article-title>. <source>Contemp Clin Trials Commun</source><year>2018</year>;<volume>10</volume>:<fpage>161</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.conctc.2018.05.007</pub-id><pub-id pub-id-type="pmid">30035241</pub-id></mixed-citation>
              </ref>
              <ref id="R35">
                <label>35</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lomas</surname><given-names>J</given-names></string-name></person-group>. <article-title>Diffusion, dissemination, and implementation: who should do what</article-title><source>Ann N Y Acad Sci</source><year>1993</year>;<volume>703</volume>:<fpage>226</fpage>–<lpage>35</lpage>; <pub-id pub-id-type="doi">10.1111/j.1749-6632.1993.tb26351.x</pub-id><pub-id pub-id-type="pmid">8192299</pub-id></mixed-citation>
              </ref>
              <ref id="R36">
                <label>36</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McCormack</surname><given-names>L</given-names></string-name>, <string-name><surname>Sheridan</surname><given-names>S</given-names></string-name>, <string-name><surname>Lewis</surname><given-names>M</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Communication and dissemination strategies to facilitate the use of health-related evidence</article-title>. <source>Evid Rep Technol Assess (Full Rep)</source><year>2013</year>:<fpage>1</fpage>–<lpage>520</lpage>. <pub-id pub-id-type="doi">10.23970/ahrqepcerta213</pub-id></mixed-citation>
              </ref>
              <ref id="R37">
                <label>37</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Holliday</surname><given-names>CS</given-names></string-name>, <string-name><surname>Williams</surname><given-names>J</given-names></string-name>, <string-name><surname>Salcedo</surname><given-names>V</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Clinical identification and referral of adults with Prediabetes to a diabetes prevention program</article-title>. <source>Prev Chronic Dis</source><year>2019</year>;<volume>16</volume>:<elocation-id>E82</elocation-id>. <pub-id pub-id-type="doi">10.5888/pcd16.180540</pub-id><pub-id pub-id-type="pmid">31255186</pub-id></mixed-citation>
              </ref>
              <ref id="R38">
                <label>38</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nhim</surname><given-names>K</given-names></string-name>, <string-name><surname>Khan</surname><given-names>T</given-names></string-name>, <string-name><surname>Gruss</surname><given-names>S</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Facilitators to referrals to CDC's National diabetes prevention program in primary care practices and pharmacies: Docstyles 2016-2017</article-title>. <source>Prev Med</source><year>2021</year>;<volume>149</volume>:<elocation-id>S0091-7435(21)00198-5</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.ypmed.2021.106614</pub-id></mixed-citation>
              </ref>
              <ref id="R39">
                <label>39</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kirley</surname><given-names>K</given-names></string-name>, <string-name><surname>Khan</surname><given-names>T</given-names></string-name>, <string-name><surname>Aquino</surname><given-names>G</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Using a certified electronic health record technology platform to screen, test and refer patients with Prediabetes</article-title>. <source>JAMIA Open</source><year>2021</year>;<volume>4</volume>:<elocation-id>ooab101</elocation-id>. <pub-id pub-id-type="doi">10.1093/jamiaopen/ooab101</pub-id><pub-id pub-id-type="pmid">34870108</pub-id></mixed-citation>
              </ref>
              <ref id="R40">
                <label>40</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Porter</surname><given-names>G</given-names></string-name>, <string-name><surname>Michaud</surname><given-names>TL</given-names></string-name>, <string-name><surname>Schwab</surname><given-names>RJ</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Reach outcomes and costs of different physician referral strategies for a weight management program among rural primary care patients: type 3 hybrid effectiveness-implementation trial</article-title>. <source>JMIR Form Res</source><year>2021</year>;<volume>5</volume>:<elocation-id>e28622</elocation-id>. <pub-id pub-id-type="doi">10.2196/28622</pub-id><pub-id pub-id-type="pmid">34668873</pub-id></mixed-citation>
              </ref>
              <ref id="R41">
                <label>41</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilson</surname><given-names>KE</given-names></string-name>, <string-name><surname>Michaud</surname><given-names>TL</given-names></string-name>, <string-name><surname>Almeida</surname><given-names>FA</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Using a population health management approach to enroll participants in a diabetes prevention trial: reach outcomes from the predicts randomized clinical trial</article-title>. <source>Transl Behav Med</source><year>2021</year>;<volume>11</volume>:<fpage>1066</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">33677529</pub-id></mixed-citation>
              </ref>
              <ref id="R42">
                <label>42</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Center</surname><given-names>PR</given-names></string-name></person-group>. <source>Mobile Fact Sheet</source>, <year>2021</year><comment>Available</comment>. <uri xlink:href="https://www.pewresearch.org/internet/fact-sheet/mobile">https://www.pewresearch.org/internet/fact-sheet/mobile</uri></mixed-citation>
              </ref>
              <ref id="R43">
                <label>43</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cole-Lewis</surname><given-names>H</given-names></string-name>, <string-name><surname>Kershaw</surname><given-names>T</given-names></string-name></person-group>. <article-title>Text Messaging as a tool for behavior change in disease prevention and management</article-title>. <source>Epidemiol Rev</source><year>2010</year>;<volume>32</volume>:<fpage>56</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1093/epirev/mxq004</pub-id><pub-id pub-id-type="pmid">20354039</pub-id></mixed-citation>
              </ref>
              <ref id="R44">
                <label>44</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gurol-Urganci</surname><given-names>I</given-names></string-name>, <string-name><surname>de Jongh</surname><given-names>T</given-names></string-name>, <string-name><surname>Vodopivec-Jamsek</surname><given-names>V</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Mobile phone Messaging reminders for attendance at Healthcare appointments</article-title>. <source>Cochrane Database Syst Rev</source><year>2013</year>;<volume>2013</volume>:<elocation-id>CD007458</elocation-id>. <pub-id pub-id-type="doi">10.1002/14651858.CD007458.pub3</pub-id><pub-id pub-id-type="pmid">24310741</pub-id></mixed-citation>
              </ref>
              <ref id="R45">
                <label>45</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Head</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Noar</surname><given-names>SM</given-names></string-name>, <string-name><surname>Iannarino</surname><given-names>NT</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Efficacy of text messaging-based interventions for health promotion: a meta-analysis</article-title>. <source>Soc Sci Med</source><year>2013</year>;<volume>97</volume>:<fpage>41</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">24161087</pub-id></mixed-citation>
              </ref>
              <ref id="R46">
                <label>46</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schwebel</surname><given-names>FJ</given-names></string-name>, <string-name><surname>Larimer</surname><given-names>ME</given-names></string-name></person-group>. <article-title>Using text message reminders in health care services: A narrative literature review</article-title>. <source>Internet Interv</source><year>2018</year>;<volume>13</volume>:<fpage>82</fpage>–<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1016/j.invent.2018.06.002</pub-id><pub-id pub-id-type="pmid">30206523</pub-id></mixed-citation>
              </ref>
              <ref id="R47">
                <label>47</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vodopivec-Jamsek</surname><given-names>V</given-names></string-name>, <string-name><surname>de Jongh</surname><given-names>T</given-names></string-name>, <string-name><surname>Gurol-Urganci</surname><given-names>I</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Mobile phone messaging for preventive health care</article-title>. <source>Cochrane Database Syst Rev</source><year>2012</year>;<volume>12</volume>:<fpage>CD007457</fpage>.<pub-id pub-id-type="pmid">23235643</pub-id></mixed-citation>
              </ref>
              <ref id="R48">
                <label>48</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><collab>USDHHS</collab></person-group>. <source>Using Health Text Messages To Improve Consumer Health Knowledge, Behaviors, And Outcomes: An Environmental Scan</source>. <publisher-loc>Rockville, MD</publisher-loc>: <publisher-name>US Department of Health and Human Services</publisher-name>, <year>2014</year>.</mixed-citation>
              </ref>
              <ref id="R49">
                <label>49</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McBrien</surname><given-names>KA</given-names></string-name>, <string-name><surname>Ivers</surname><given-names>N</given-names></string-name>, <string-name><surname>Barnieh</surname><given-names>L</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Patient navigators for people with chronic disease: A systematic review</article-title>. <source>PLoS One</source><year>2018</year>;<volume>13</volume>:<elocation-id>e0191980</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0191980</pub-id><pub-id pub-id-type="pmid">29462179</pub-id></mixed-citation>
              </ref>
              <ref id="R50">
                <label>50</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vinci</surname><given-names>C</given-names></string-name>, <string-name><surname>Lam</surname><given-names>C</given-names></string-name>, <string-name><surname>Schlechter</surname><given-names>CR</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Increasing treatment enrollment among Smokers who are not motivated to quit: a randomized clinical trial</article-title>. <source>Transl Behav Med</source><year>2022</year>;<volume>12</volume>:<elocation-id>ibab114</elocation-id>. <pub-id pub-id-type="doi">10.1093/tbm/ibab114</pub-id><pub-id pub-id-type="pmid">34424337</pub-id></mixed-citation>
              </ref>
              <ref id="R51">
                <label>51</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peart</surname><given-names>A</given-names></string-name>, <string-name><surname>Lewis</surname><given-names>V</given-names></string-name>, <string-name><surname>Brown</surname><given-names>T</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Patient navigators facilitating access to primary care: a Scoping review</article-title>. <source>BMJ Open</source><year>2018</year>;<volume>8</volume>:<elocation-id>e019252</elocation-id>. <pub-id pub-id-type="doi">10.1136/bmjopen-2017-019252</pub-id></mixed-citation>
              </ref>
              <ref id="R52">
                <label>52</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Valaitis</surname><given-names>RK</given-names></string-name>, <string-name><surname>Carter</surname><given-names>N</given-names></string-name>, <string-name><surname>Lam</surname><given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Implementation and maintenance of patient navigation programs linking primary care with community-based health and social services: a Scoping literature review</article-title>. <source>BMC Health Serv Res</source><year>2017</year>;<volume>17</volume>:<elocation-id>116</elocation-id>. <pub-id pub-id-type="doi">10.1186/s12913-017-2046-1</pub-id><pub-id pub-id-type="pmid">28166776</pub-id></mixed-citation>
              </ref>
              <ref id="R53">
                <label>53</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Almirall</surname><given-names>D</given-names></string-name>, <string-name><surname>Collins</surname><given-names>LM</given-names></string-name>, <string-name><surname>Murphy</surname><given-names>SA</given-names></string-name></person-group>. <article-title>Introduction to adaptive interventions and smart study design principles</article-title>. <source>COPTR Workshop on Adaptive Interventions</source><year>2011</year>.</mixed-citation>
              </ref>
              <ref id="R54">
                <label>54</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bierman</surname><given-names>KL</given-names></string-name>, <string-name><surname>Nix</surname><given-names>RL</given-names></string-name>, <string-name><surname>Maples</surname><given-names>JJ</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Examining clinical judgment in an adaptive intervention design: the fast track program</article-title>. <source>J Consult Clin Psychol</source><year>2006</year>;<volume>74</volume>:<fpage>468</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1037/0022-006X.74.3.468</pub-id><pub-id pub-id-type="pmid">16822104</pub-id></mixed-citation>
              </ref>
              <ref id="R55">
                <label>55</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McKay</surname><given-names>JR</given-names></string-name></person-group>. <article-title>Is there a case for extended interventions for alcohol and drug use disorders</article-title><source>Addiction</source><year>2005</year>;<volume>100</volume>:<fpage>1594</fpage>–<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1111/j.1360-0443.2005.01208.x</pub-id><pub-id pub-id-type="pmid">16277622</pub-id></mixed-citation>
              </ref>
              <ref id="R56">
                <label>56</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lei</surname><given-names>H</given-names></string-name>, <string-name><surname>Nahum-Shani</surname><given-names>I</given-names></string-name>, <string-name><surname>Lynch</surname><given-names>K</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>A" SMART" design for building individualized treatment sequences</article-title>. <source>Annu Rev Clin Psychol</source><year>2012</year>;<volume>8</volume>:<fpage>21</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-clinpsy-032511-143152</pub-id><pub-id pub-id-type="pmid">22224838</pub-id></mixed-citation>
              </ref>
              <ref id="R57">
                <label>57</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lavori</surname><given-names>PW</given-names></string-name>, <string-name><surname>Dawson</surname><given-names>R</given-names></string-name></person-group>. <article-title>Introduction to dynamic treatment strategies and sequential multiple assignment randomization</article-title>. <source>Clin Trials</source><year>2014</year>;<volume>11</volume>:<fpage>393</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1177/1740774514527651</pub-id><pub-id pub-id-type="pmid">24784487</pub-id></mixed-citation>
              </ref>
              <ref id="R58">
                <label>58</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Murphy</surname><given-names>SA</given-names></string-name></person-group>. <article-title>An experimental design for the development of adaptive treatment strategies</article-title>. <source>Stat Med</source><year>2005</year>;<volume>24</volume>:<fpage>1455</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1002/sim.2022</pub-id><pub-id pub-id-type="pmid">15586395</pub-id></mixed-citation>
              </ref>
              <ref id="R59">
                <label>59</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Miller</surname><given-names>WR</given-names></string-name>, <string-name><surname>Rollnick</surname><given-names>S</given-names></string-name></person-group>. <source>Motivational Interviewing: Preparing People to Change Addictive Behavior</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>The Guildford Press</publisher-name>, <year>1991</year>.</mixed-citation>
              </ref>
              <ref id="R60">
                <label>60</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Miller</surname><given-names>WR</given-names></string-name>, <string-name><surname>Rollnick</surname><given-names>S</given-names></string-name></person-group>. <source>Motivational Interviewing, 2nd edn</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>The Guilford Press</publisher-name>, <year>2002</year>.</mixed-citation>
              </ref>
              <ref id="R61">
                <label>61</label>
                <mixed-citation publication-type="book"><person-group person-group-type="editor"><string-name><surname>Marlatt</surname><given-names>G</given-names></string-name>, <string-name><surname>Donovan</surname><given-names>D</given-names></string-name></person-group>, eds. <source>Relapse prevention: Maintenance strategies in the treatment of addictive behaviors, 2nd edn</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Guilford Press</publisher-name>, <year>2005</year>.</mixed-citation>
              </ref>
              <ref id="R62">
                <label>62</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Witkiewitz</surname><given-names>K</given-names></string-name>, <string-name><surname>Marlatt</surname><given-names>GA</given-names></string-name></person-group>. <article-title>Relapse prevention for alcohol and drug problems: that was Zen, this is Tao</article-title>. <source>Am Psychol</source><year>2004</year>;<volume>59</volume>:<fpage>224</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1037/0003-066X.59.4.224</pub-id><pub-id pub-id-type="pmid">15149263</pub-id></mixed-citation>
              </ref>
              <ref id="R63">
                <label>63</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Reitzel</surname><given-names>LR</given-names></string-name>, <string-name><surname>Vidrine</surname><given-names>JI</given-names></string-name>, <string-name><surname>Businelle</surname><given-names>MS</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Preventing postpartum smoking relapse among diverse low-income women: a randomized clinical trial</article-title>. <source>Nicotine Tob Res</source><year>2010</year>;<volume>12</volume>:<fpage>326</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1093/ntr/ntq001</pub-id><pub-id pub-id-type="pmid">20154055</pub-id></mixed-citation>
              </ref>
              <ref id="R64">
                <label>64</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Correa-Fernández</surname><given-names>V</given-names></string-name>, <string-name><surname>Díaz-Toro</surname><given-names>EC</given-names></string-name>, <string-name><surname>Reitzel</surname><given-names>LR</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Combined treatment for at-risk drinking and smoking cessation among Puerto Ricans: A randomized clinical trial</article-title>. <source>Addict Behav</source><year>2017</year>;<volume>65</volume>:<fpage>185</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.addbeh.2016.10.009</pub-id><pub-id pub-id-type="pmid">27825036</pub-id></mixed-citation>
              </ref>
              <ref id="R65">
                <label>65</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McClure</surname><given-names>JB</given-names></string-name>, <string-name><surname>Westbrook</surname><given-names>E</given-names></string-name>, <string-name><surname>Curry</surname><given-names>SJ</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Proactive, motivationally enhanced smoking cessation counseling among women with elevated cervical cancer risk</article-title>. <source>Nicotine Tob Res</source><year>2005</year>;<volume>7</volume>:<fpage>881</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">16298723</pub-id></mixed-citation>
              </ref>
              <ref id="R66">
                <label>66</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wetter</surname><given-names>DW</given-names></string-name>, <string-name><surname>Mazas</surname><given-names>C</given-names></string-name>, <string-name><surname>Daza</surname><given-names>P</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Reaching and treating Spanish-speaking Smokers through the National Cancer Institute's cancer information service. A randomized controlled trial</article-title>. <source>Cancer</source><year>2007</year>;<volume>109</volume>:<fpage>406</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1002/cncr.22360</pub-id><pub-id pub-id-type="pmid">17149758</pub-id></mixed-citation>
              </ref>
              <ref id="R67">
                <label>67</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Conroy</surname><given-names>DE</given-names></string-name>, <string-name><surname>Elavsky</surname><given-names>S</given-names></string-name>, <string-name><surname>Hyde</surname><given-names>AL</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>The dynamic nature of physical activity intentions: a within-person perspective on intention-behavior coupling</article-title>. <source>J Sport Exerc Psychol</source><year>2011</year>;<volume>33</volume>:<fpage>807</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1123/jsep.33.6.807</pub-id><pub-id pub-id-type="pmid">22262706</pub-id></mixed-citation>
              </ref>
              <ref id="R68">
                <label>68</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maher</surname><given-names>JP</given-names></string-name>, <string-name><surname>Dunton</surname><given-names>GF</given-names></string-name></person-group>. <article-title>Within-day time-varying associations between motivation and movement-related behaviors in older adults</article-title>. <source>Psychol Sport Exercise</source><year>2020</year>;<volume>47</volume>. <pub-id pub-id-type="doi">10.1016/j.psychsport.2019.04.012</pub-id></mixed-citation>
              </ref>
              <ref id="R69">
                <label>69</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vartanian</surname><given-names>LR</given-names></string-name>, <string-name><surname>Pinkus</surname><given-names>RT</given-names></string-name>, <string-name><surname>Smyth</surname><given-names>JM</given-names></string-name></person-group>. <article-title>Experiences of weight stigma in everyday life: implications for health motivation</article-title>. <source>Stigma and Health</source><year>2018</year>;<volume>3</volume>:<fpage>85</fpage>–<lpage>92</lpage>.</mixed-citation>
              </ref>
              <ref id="R70">
                <label>70</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vidrine</surname><given-names>JI</given-names></string-name>, <string-name><surname>Reitzel</surname><given-names>LR</given-names></string-name>, <string-name><surname>Figueroa</surname><given-names>PY</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Motivation and problem solving (MAPS): Motivationally-based skills training for treating substance use</article-title>. <source>Cogn Behav Pract</source><year>2013</year>;<volume>20</volume>:<fpage>501</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpra.2011.11.001</pub-id><pub-id pub-id-type="pmid">33239855</pub-id></mixed-citation>
              </ref>
              <ref id="R71">
                <label>71</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><collab>Centers for Disease Control Prevention ADA</collab></person-group>. <source>Predaibetes risk test</source>. <comment>Available</comment>: <uri xlink:href="https://www.cdc.gov/diabetes/prevention/pdf/Prediabetes-Risk-Test-Final.pdf">https://www.cdc.gov/diabetes/prevention/pdf/Prediabetes-Risk-Test-Final.pdf</uri></mixed-citation>
              </ref>
              <ref id="R72">
                <label>72</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bullard</surname><given-names>KM</given-names></string-name>, <string-name><surname>Saydah</surname><given-names>SH</given-names></string-name>, <string-name><surname>Imperatore</surname><given-names>G</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Secular changes in US Prediabetes prevalence defined by hemoglobin A1C and fasting plasma glucose: national health and nutrition examination surveys, 1999–2010</article-title>. <source>Diabetes Care</source><year>2013</year>;<volume>36</volume>:<fpage>2286</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.2337/dc12-2563</pub-id><pub-id pub-id-type="pmid">23603918</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
